The innovative research conducted by our physicians and faculty has paved the way for more effective methods of prevention, diagnosis, and treatment of gastrointestinal diseases.
In our mission to create knowledge through research, the Division of Gastroenterology and Hepatology continues to conduct cutting-edge investigations of the molecular, cellular, and physiological conditions of healthy and diseased states of the gastrointestinal tract, liver, and pancreas. The central piece of the Division's research endeavor is the NIH-funded University of Michigan Center for Gastrointestinal Research, which encompasses three thematic areas of research:
- neurobiology of appetite control and visceral pain
- molecular and cellular mechanisms of inflammation
- cell growth, differentiation, and programmed cell death
Pratima Sharma, MD, MS and team analyze death risk from COVID-19 in organ transplant recipients and find one treatment method greatly increased the risk.
Monica Tincopa, MD, MSc and team look into the prevalence of NAFLD in patients with heart failure with preserved ejection fraction.
Shirley Ann Cohen-Mekelburg, MD, MS examines how a lack of coordination in care among doctors and facilities impacts veterans with inflammatory bowel disease.
Joel Rubenstein, MD, MSc and team examine the relationship between proton pump inhibitors, endoscopy, esophageal conditions, and psychological distress for patients with GERD.